2011
The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab
Lee ST, Adelman RA. The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab. Journal Of Ocular Pharmacology And Therapeutics 2011, 27: 611-614. PMID: 21810026, DOI: 10.1089/jop.2011.0045.Peer-Reviewed Original ResearchConceptsRecurrent central serous chorioretinopathyMean central macular thicknessCentral macular thicknessCentral serous chorioretinopathyPreinjection visual acuityVisual acuityOptical coherence tomographyIntravitreal bevacizumabSerous chorioretinopathyTreatment optionsLow-risk treatment optionYale Eye CenterIntravitreal bevacizumab injectionRetrospective case seriesEffective treatment optionLong-term efficacySub-retinal fluidNumber of injectionsFluorescein angiography imagingBevacizumab injectionRecurrent diseaseMacular thicknessMonth 3Month 6Case series
2010
Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections
Adelman RA, Zheng Q, Mayer HR. Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections. Journal Of Ocular Pharmacology And Therapeutics 2010, 26: 105-110. PMID: 20187807, DOI: 10.1089/jop.2009.0076.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumabDrug Administration ScheduleDrug Therapy, CombinationFemaleHumansInjections, IntraocularIntraocular PressureMacular DegenerationMaleOcular HypertensionRanibizumabRetrospective StudiesTime FactorsVascular Endothelial Growth Factor AVitreous BodyConceptsAge-related macular degenerationPersistent ocular hypertensionOcular hypertensionIntraocular pressureIntravitreal bevacizumabRanibizumab injectionsIntravitreal injectionPrevious diagnosisGlaucoma/ocular hypertensionIntravitreal anti-VEGF injectionsAnti-VEGF injectionsIntravitreal bevacizumab injectionPostinjection intraocular pressurePreinjection intraocular pressureMultiple intravitreal injectionsTertiary referral centerRetrospective case seriesElevated intraocular pressureBevacizumab injectionIntravitreal ranibizumabReferral centerCase seriesVEGF injectionIOP increaseYAG capsulotomy
2005
The Effectiveness of Isobutyl Cyanoacrylate Tissue Adhesive for the Treatment of Corneal Perforations
Setlik DE, Seldomridge DL, Adelman RA, Semchyshyn TM, Afshari NA. The Effectiveness of Isobutyl Cyanoacrylate Tissue Adhesive for the Treatment of Corneal Perforations. American Journal Of Ophthalmology 2005, 140: 920-921. PMID: 16310475, DOI: 10.1016/j.ajo.2005.04.062.Peer-Reviewed Original Research
2003
Cataract formation after initial trabeculectomy in young patients
Adelman RA, Brauner SC, Afshari NA, Grosskreutz CL. Cataract formation after initial trabeculectomy in young patients. Ophthalmology 2003, 110: 625-629. PMID: 12623833, DOI: 10.1016/s0161-6420(02)01769-4.Peer-Reviewed Original ResearchConceptsInitial trabeculectomyYounger patientsCataract extractionCataract formationType of glaucomaNoncomparative case seriesMain outcome measuresSteroid-induced glaucomaLens statusCommon complicationFirst eyeFellow eyesCase seriesCataract progressionEar InfirmaryLenticular opacificationLenticular opacitiesOutcome measuresMAIN OUTCOMETrabeculectomyMassachusetts EyePatientsConsultation serviceSignificant riskMonths